Company Cash Funds: Qiagen NV (QGEN)

Brandmark of Qiagen N.V. (QGEN)

The potential of Qiagen N.V. (QGEN) relies on its dominance in laboratory equipment, as evidenced by changes in cash levels; 0.82 captures the current state of this parameter. The "printer-cartridge" model with closed reagents creates strong customer lock-in, while a flawless image as a global leader in genetics minimizes reputational risks, ensuring business stability within the DNA technology sector.

QGEN - Qiagen Group Company Cash and Cash Equivalents over the range 07/04/2022 - 11/21/2026

Analytical breakdowns for Qiagen N.V.

- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
Initial company analysis:qiagen.com
Brand item of Qiagen

Steady demand for molecular research consumables provides Qiagen N.V. (QGEN) with a predictable inflow of liquidity. By analyzing the cash position chart, an investor can see the issuer's current financial reserve. Daily calculation of this metric allows for real-time tracking of the "safety cushion" without waiting for quarterly reports. Growth in this indicator confirms the business's high resilience to default, although excess cash may suggest an underutilization of capital.

Main competitors

Company Cash Volume TEM|IONS - Company Cash Reserve|Company Cash Funds Repligen RGEN|RNA: Company Cash and Cash Equivalents|CRSP: Company Cash on Hand|GeneDx Corp (WGS) - Company Cash on Hand|RARE: Company Cash Volume|BEAM - Company Liquid Assets|SRPT (Sarepta Therapeutics) - Company Cash Volume|Company Cash on Hand Twist Bioscience Inc (TWST)|Company Cash Volume TXG|Company Liquid Assets Intellia|Stoke - Company Cash on Hand|BLFS: Company Cash and Cash Equivalents|Wave Life Sciences Corp - Company Cash Volume|Maze Therapeutics, Inc. (MAZE) - Company Cash on Hand|Sionna Therapeutics Inc (SION) - Company Cash Funds|Company Cash on Hand Prime Medicine Corp|Company Cash Funds tayshagtx.com|QURE - Company Cash Position|Company Cash on Hand MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Company Cash Position|Company Cash Volume SLDB (Solid Biosciences Inc.)|Company Cash Balance OCGN|PacBio Corp - Company Cash Volume|Benitec Biopharma Inc. (BNTC) - Company Cash on Hand|DSGN: Company Cash Volume|Company Cash and Cash Equivalents RCKT|Company Cash on Hand FDMT|Company Cash and Cash Equivalents LXEO (Lexeo Therapeutics)|Company Cash Volume KRRO|Editas Medicine, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Silence Therapeutics Inc. SLN|Company Cash Volume ProQR Therapeutics N.V. PRQR|CDXS: Company Cash on Hand|Company Cash Position Sangamo (SGMO)|NAUT (Nautilus Bio) - Company Cash on Hand|MGX - Company Liquid Assets|DTIL (Precision BioSciences Inc.) - Company Cash Volume|generationbio.com (GBIO) - Company Liquid Assets|Company Cash Funds Boundless Bio Inc (BOLD)|Company Cash Volume Exicure Inc. (XCUR)|Company Cash Funds imunon.com IMNN|Company Cash Volume Phio Pharmaceuticals PHIO|Mustang Bio Inc - Company Cash Volume|Company Cash Reserve transcodetherapeutics.com|BNGO: Company Cash Volume|Company Cash and Cash Equivalents APDN|BLUE (bluebirdbio.com) - Company Cash Volume|Company Cash Reserve ImmunoPrecise Antibodies IPA|Company Cash on Hand OMGA (omegatherapeutics.com)|Company Cash Volume Singular Genomics Systems, Inc. (OMIC)|Company Cash Volume RGLS (Regulus Therapeutics, Inc.)|Company Cash Volume Syros SYRS|Telesis Bio, Inc. - Company Cash Volume|TRACON Pharmaceuticals (TCON) - Company Cash on Hand|UBX: Company Cash Volume